Circulating serum miR‐223‐3p and miR‐16‐5p as possible biomarkers of early rheumatoid arthritis

Por Dunaeva, M., Blom, J., Thurlings, R., Pruijn, G. J. M.
Publicado no Clin Exp Immunol (2018)

Characterization of murine monoclonal antibodies against the Ro52 autoantigen

Por SCHMITZ, M, BACHMANN, M, LAÜBINGER, J, THIJSSEN, J P H, PRUIJN, G J M
Publicado em 1997

Anti-Ro52 antibodies frequently co-occur with anti-Jo-1 antibodies in sera from patients with idiopathic inflammatory myopathy

Por RUTJES, S A, VREE EGBERTS, W T M, JONGEN, P, VAN DEN HOOGEN, F, PRUIJN, G J M, VAN VENROOIJ, W J
Publicado em 1997

Anti‐cyclic citrullinated peptide positivity in non‐rheumatoid arthritis disease samples: citrulline‐dependent or not?

Por Vannini, A, Cheung, K, Fusconi, M, Stammen‐Vogelzangs, J, Drenth, J P H, Dall'Aglio, A C, Bianchi, F B, Bakker‐Jonges, L E, van Venrooij, W J, Pruijn, G J M, Zendman, A J W
Publicado em 2007

Autoantibodies against small nucleolar ribonucleoprotein complexes and their clinical associations

Por VAN EENENNAAM, H, VOGELZANGS, J H P, BISSCHOPS, L, TE BOOME, L C J, SEELIG, H P, RENZ, M, DE ROOIJ, D -J, BROUWER, R, PLUK, H, PRUIJN, G J M, VAN VENROOIJ, W J, VAN DEN HOOGEN, F H J
Publicado em 2002

Cytosolic 5′-nucleotidase 1A autoantibody profile and clinical characteristics in inclusion body myositis

Por Lilleker, J B, Rietveld, A, Pye, S R, Mariampillai, K, Benveniste, O, Peeters, M T J, Miller, J A L, Hanna, M G, Machado, P M, Parton, M J, Gheorghe, K R, Badrising, U A, Lundberg, I E, Sacconi, S, Herbert, M K, McHugh, N J, Lecky, B R F, Brierley, C, Hilton-Jones, D, Lamb, J A, Roberts, M E, Cooper, R G, Saris, C G J, Pruijn, G J M, Chinoy, H, van Engelen, B G M
Publicado no Ann Rheum Dis (2017)